ACTUATE THERAPEUTICS, INC. financial data

Symbol
ACTU on Nasdaq
Location
Fort Worth, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 112% %
Debt-to-equity 1067% %
Return On Equity -2924% % -8228%
Return On Assets -251% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23,243,328 shares 19%
Common Stock, Shares, Outstanding 23,243,328 shares 19%
Common Stock, Value, Issued $23 USD 15%
Weighted Average Number of Shares Outstanding, Basic 21,394,965 shares 99%
Weighted Average Number of Shares Outstanding, Diluted 21,394,965 shares 99%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $11,848,985 USD -42%
General and Administrative Expense $12,516,982 USD 101%
Operating Income (Loss) $24,365,967 USD -1.5%
Nonoperating Income (Expense) $245,979 USD
Net Income (Loss) Attributable to Parent $24,119,988 USD 15%
Earnings Per Share, Basic 6 USD/shares 55%
Earnings Per Share, Diluted 6 USD/shares 55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $16,924,763 USD 25%
Assets, Current $17,444,000 USD 22%
Other Assets, Noncurrent $269,934 USD
Assets $17,713,934 USD 24%
Accounts Payable, Current $1,245,375 USD -47%
Liabilities, Current $6,372,662 USD -25%
Liabilities $6,777,653 USD -24%
Retained Earnings (Accumulated Deficit) $150,053,748 USD -19%
Stockholders' Equity Attributable to Parent $10,936,281 USD 104%
Liabilities and Equity $17,713,934 USD 24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,618,740 USD 12%
Net Cash Provided by (Used in) Financing Activities $133,477 USD -103%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 23,243,328 shares 19%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16,924,763 USD 25%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $160,990,006 USD 23%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $5,696,573 USD 218%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%